MedPath

Reflucon

Brand Name: Reflucon

Generic Name: Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate

Active
Registration Number

DRP-12184-01

Dosage Form

Oral Suspension

Issuance Date

January 31, 2023

Expiry Date

June 27, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500mg /213mg/325mg per 10mL
PackagingAluminum Foil Sachet x 10 mL (Box of 12's and 24's)

Classification

C
Classification
Over-the-Counter (OTC) Drug
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

Sodium AlginateActive
Monograph: Alginic acid
Sodium BicarbonateActive
Calcium CarbonateActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform